An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

One of oncology's biggest challenges is that the same treatment can work well for some patients but fail completely in others ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

A newly discovered mechanism that protects nerve cells could have important implications for understanding and treating ...

A growing field of research suggests that some medical treatments, such as cancer therapy or vaccines, might be more ...

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.

Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them ...

Today, our scientists and doctors are transforming cancer care through precision immuno-oncology — tailoring immunotherapy treatments to the unique biology of each patient's cancer. At MSK, ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and ...

In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...